消費者保健(CHC)市場檢討:2023年中間報告
市場調查報告書
商品編碼
1323307

消費者保健(CHC)市場檢討:2023年中間報告

Mid-2023 CHC Review

出版日期: | 出版商: Nicholas Hall Group of Companies | 英文 90 Pages | 訂單完成後即時交付

價格
簡介目錄

本報告提供消費者保健(CHC)市場相關調查,彙整各市場分類的銷售額實際成果和趨勢,前12名市場(美國,中國,德國,巴西,義大利,印度等)的最新趨勢,及今後的短期及2027年及到2032年為止的長期預測等資料。

範例視圖



目錄

全球概要

  • 由於微觀層面的重大變化,CHC 市場仍不穩定。
  • 競爭狀況
  • 創新與新產品開發
  • 處方藥到非處方藥的轉換

各類別趨勢

  • 止痛藥
  • 咳嗽,感冒,過敏
  • 腸胃
  • 維他命,礦物,補充品
  • 皮膚科
  • 生活方式CHC

核心市場

  • 概要
  • 美國
  • 中國
  • 日本
  • 俄羅斯
  • 德國
  • 法國
  • 義大利
  • 巴西
  • 印度
  • 英國
  • 澳洲
  • 墨西哥

預測

  • 短期預測
  • 長期預測
簡介目錄

The report features the latest MAT Q2 2023 sales data from our dedicated DB6 database, including topline historical sales globally, by region, country and category, short-term forecasts to 2023-24 and long-term forecasts to 2027 & 2032.

Find out the very latest global, regional and market-level trends in CHC Access the newest sales data, freshly published by DB6 Read fresh analysis of category trends, brand activity and regulatory updates Get your hands on the most up-to-date short-term forecasts

Four concise chapters cover all the key insights you need:

  • Global Overview
  • Category Trends
  • Core Markets
  • Outlook

SAMPLE VIEW



Nicholas Hall's “Mid-2023 CHC Review”, charts the very latest CHC sales, growth drivers and forecasts in a succinct topical review.

Over 90 detail-packed pages, it probes the most important CHC market influences globally, across categories and individual markets, while casting an eye to the future.

The report features the latest MAT Q2 2023 sales data from our dedicated DB6 database, including topline historical sales globally, by region, country and category, short-term forecasts to 2023-24 and long-term forecasts to 2027 & 2032.

Featuring sales for the 12-month period ending June 2023, plus y-o-y growth rates, the report includes over 60 unique sales charts. Historical growth rates 2019-22 are included to help chronicle performance fluctuations over time.

Global Overview delves into the CHC market's performance and tracks the latest happenings in Switch, Innovation, M&A and beyond.

Charts include:

  • Global CHC sales mid-2022 & mid-20231
  • Global CHC sales by region mid-20232
  • Global CHC sales by major category mid-20232
  • Global Top 10 CHC players mid-20232

Covering all six major categories in turn, Category Trends charts the factors impacting Analgesics, CCA, GIs, VMS, Derma and Lifestyle CHC, casting the spotlight on individual subcategories.

Charts include:

  • Global [major category] sales mid-2022 & mid-20231
  • Global [major category] sales by subcategory mid-20232
  • Global leading [major category] brands mid-20232

Core Markets assesses the most recent developments in each of the Top 12 markets (including USA, China, Germany, Brazil, Italy, India and more), appraising performances and trends category by category.

Charts include:

  • Global leading CHC markets mid-20232
  • [Market] CHC sales mid-2022 & mid-20231
  • [Market] CHC sales by major category mid-20232
  • [Market] leading marketers & brands mid-20232

Evaluating the future of CHC, the Outlook chapter considers the prospects & challenges facing CHC players, alongside short- and long-term forecast sales.

Charts include:

  • Global short-term forecast sales by
  • major category / by region 2023-24
  • Global 5 & 10 year forecast sales by
  • major category / by region 2027 & 2032

1including historical growth rates; 2including CAGR 22/18.

Table of Contents

Global Overview

  • Key shifts at the micro-level see CHC market remain in flux
  • Competitive landscape
  • Innovation & NPD
  • Rx-to-OTC switch

Category Trends

  • Analgesics
  • Cough, Cold & Allergy
  • Gastrointestinals
  • Vitamins, Minerals & Supplements
  • Dermatologicals
  • Lifestyle CHC

Core Markets

  • Overview
  • USA
  • China
  • Japan
  • Russia
  • Germany
  • France
  • Italy
  • Brazil
  • India
  • UK
  • Australia
  • Mexico

Outlook

  • Short-term forecast
  • Long-term forecast